Nov 24 (Reuters) - Somnomed Ltd (SOM) :
- TECHNOLOGY DEVELOPMENT EXPENDITURE IS EXPECTED TO DECLINE OVER FY24
- CONFIDENT IN ABILITY TO DELIVER PROVIDED GUIDANCE OF REVENUE GROWTH OF AT LEAST 12% AND EBITDA OF AT LEAST A$3 MILLION IN FY24
- REMAINS OPTIMISTIC ABOUT ITS CORE TRADING ACTIVITY LEVELS AND OUTLOOK FOR COMMERCIALISATION OF REST ASSURE IN FY24
- FY24 CAPEX INVESTMENT GUIDANCE OF A$5 MILLION
News: SOM Somnomed Says Technology Development Expenditure Is Expected To Decline Over FY24
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
73.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $159.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7877 | 71.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 75.0¢ | 129919 | 2 |
View Market Depth
| Last trade - 10.24am 09/09/2025 (20 minute delay) ? |
| SOM (ASX) Chart |
Day chart unavailable